Cell Stem Cell is Cell Press's stem-cell journal. Cancer readers go to it for leukaemia stem cell and clonal haematopoiesis biology, patient-derived organoid biobanks used for drug testing, and induced pluripotent stem cell-derived immune cells for off-the-shelf cell therapies; access is hybrid.
Cell Stem Cell is Cell Press's stem-cell journal, founded in 2007, appearing monthly and published by Cell Press (Elsevier) on a hybrid model. It publishes haematopoietic and cancer stem cell biology, patient-derived organoid biobanks used for drug testing, and induced-pluripotent-stem-cell-derived immune cells for allogeneic cell therapy. For cancer readers its relevance lies in leukaemia stem cells, clonal haematopoiesis, organoid models and off-the-shelf cell therapies. Within OnCo it is linked from the Patient-derived organoids technology entry and the Michael Teitell biography, and it is where a reader would look for organoid biobank and cell-therapy engineering papers.